By using peptide-primarily based procedures to inhibit anti-apoptotic proteins like BCL-2, programmed mobile death may be induced in cancer cells, ultimately leading to their demise. These qualified methodologies show encouraging brings about augmenting the success of cancer therapy and improving affected individual outcomes. Latest strides in p